Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miza Pharmaceuticals was a privately held Canadian pharmaceutical contract development and manufacturing company focused on niche sterile pharmaceutical products rather than discovery-stage therapeutics. The company provided development-led manufacturing services to pharmaceutical, biotechnology, and medical device customers, with capabilities spanning ophthalmic solutions, respiratory inhalation products, topical aerosols, and sterile hospital solutions. Its manufacturing platform emphasized proprietary Blow/Fill/Seal technology and other aseptic processing methods. Miza also operated through subsidiaries in the United States and the United Kingdom and expanded through acquisitions of manufacturing assets and ophthalmic product facilities. Available records indicate that the historical Miza Pharmaceuticals entities were later dissolved or became inactive, so the company appears to be defunct today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miza Pharmaceuticals.